p53 Mutations in Human Cancers

<i>ras</i> GENES

Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885 · see citing works

Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms

Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765 · see citing works

Mutations in the p53 gene occur in diverse human tumour types

Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K. R., Signer, S. H., Davidson, N. E., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,730 · see citing works

Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53

Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562 · see citing works

T antigen is bound to a host protein in SY40-transformed cells

Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,443 · see citing works

Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG

Shibutani, S., Takeshita, M., & Grollman, A. P. (1991) · Nature · doi:10.1038/349431a0 · Cited by 2,224 · see citing works

Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas

Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,067 · see citing works

The p53 proto-oncogene can act as a suppressor of transformation

Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987 · see citing works

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814 · see citing works

Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53

Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742 · see citing works

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

Hsu, I., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,533 · see citing works

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

Paillerets, B. B., Kew, M. C., Wands, J. R., & Öztürk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,433 · see citing works

Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene

MELLON, I. (1987) · Cell · doi:10.1016/0092-8674(87)90151-6 · Cited by 1,228 · see citing works

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome

Srivastava, S. K., Zou, Z., Pirollo, K. F., Blattner, W. A., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,210 · see citing works

p53: A Frequent Target for Genetic Abnormalities in Lung Cancer

Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M. L., Pass, H. I., Gazdar, A. F., & Minna, J. D. (1989) · Science · doi:10.1126/science.2554494 · Cited by 1,196 · see citing works

Identification of p53 as a Sequence-Specific DNA-Binding Protein

Kern, S. E., Kinzler, K. W., Bruskin, A. M., Jarosz, D., Friedman, P. N., Prives, C. L., & Vogelstein, B. (1991) · Science · doi:10.1126/science.2047879 · Cited by 1,085 · see citing works

p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., & Vogelstein, B. (1990) · PubMed · Cited by 1,065 · see citing works

Increased expression of mutant forms of p53 oncogene in primary lung cancer

Iggo, R. D., Bártek, J., Lane, D. P., Gatter, K. C., Harris, A. L., & Bártek, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)90801-b · Cited by 1,030 · see citing works

p53 mutations in colorectal cancer.

Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J., & Lane, D. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7555 · Cited by 1,002 · see citing works

MUTAGENESIS BY APURINIC/APYRIMIDINIC SITES

Loeb, L. A., & Preston, B. D. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.001221 · Cited by 901 · see citing works

Increased cell division as a cause of human cancer.

Preston‐Martin, S., Pike, M. C., Ross, R. K., Jones, P. A., & Henderson, B. E. (1990) · PubMed · Cited by 896 · see citing works

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Gaïdano, G., Ballerini, P. F., Gong, J. Z., Inghirami, G., Neri, A., Newcomb, E. W., MAGRATH, I. T., Knowles, D., & Dalla‐Favera, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5413 · Cited by 884 · see citing works

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

Sarnow, P., Ho, Y.-S., Williams, J., & Levine, A. J. (1982) · Cell · doi:10.1016/0092-8674(82)90356-7 · Cited by 836 · see citing works

Presence of a Potent Transcription Activating Sequence in the p53 Protein

Fields, S., & Jang, S. K. (1990) · Science · doi:10.1126/science.2144363 · Cited by 790 · see citing works

p53 Functions as a Cell Cycle Control Protein in Osteosarcomas

Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M. C., Bressac, B., Öztürk, M., Baker, S. J., Vogelstein, B., et al. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 775 · see citing works

5-Methylcytosine in Eukaryotic DNA

Ehrlich, M., & Wang, R. Y. ‐. (1981) · Science · doi:10.1126/science.6262918 · Cited by 745 · see citing works

Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage.

Shigenaga, M. K., Gimeno, C. J., & Ames, B. N. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9697 · Cited by 732 · see citing works

Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome

Wood, M. L., Dizdaroğlu, M., Gajewski, E., & Essigmann, J. M. (1990) · Biochemistry · doi:10.1021/bi00482a011 · Cited by 684 · see citing works

Wild-type p53 can inhibit oncogene-mediated focus formation.

Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., & Oren, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8763 · Cited by 681 · see citing works

5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes

Rideout, W. M., Coetzee, G. A., Olumi, A. F., & Jones, P. A. (1990) · Science · doi:10.1126/science.1697983 · Cited by 640 · see citing works

Structural aspects of the p53 protein in relation to gene evolution.

Soussi, T., de Fromentel, C. C., & May, P. (1990) · PubMed · Cited by 608 · see citing works

Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.

Bártek, J., Iggo, R. D., Gannon, J., & Lane, D. P. (1990) · PubMed · Cited by 603 · see citing works

Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation

Hinds, P. W., Finlay, C. A., & Levine, A. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.739-746.1989 · Cited by 595 · see citing works

Oxidative damage to DNA: relation to species metabolic rate and life span.

Adelman, R., Saul, R. L., & Ames, B. N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2706 · Cited by 580 · see citing works

Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Chiba, I., Takahashi, T., Nau, M. M., D'Amico, D., Dt, C., Mitsudomi, T., Buchhagen, D. L., Carbone, D. P., Piantadosi, S., & KOGA, H. (1990) · PubMed · Cited by 514 · see citing works

Chemical carcinogenesis: too many rodent carcinogens.

Ames, B. N., & Gold, L. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7772 · Cited by 489 · see citing works

Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

Mercer, W. E., Shields, M. T., Amin, M., Sauvé, G. J., Appella, E., Romano, J., & Ullrich, S. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6166 · Cited by 477 · see citing works

Rearrangement of the p53 gene in human osteogenic sarcomas.

Masuda, H., Miller, C., Koeffler, H. P., Battifora, H. A., & Cline, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7716 · Cited by 473 · see citing works

The search for the causes of breast and colon cancer

Willett, W. C. (1989) · Nature · doi:10.1038/338389a0 · Cited by 466 · see citing works

Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

Paillerets, B. B., Galvin, K. M., Liang, T. J., Isselbacher, K. J., Wands, J. R., & Öztürk, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1973 · Cited by 415 · see citing works

Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.

Wolf, D., & Rotter, V. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.790 · Cited by 406 · see citing works

Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.

Menon, A. G., Anderson, K. M., Riccardi, V. M., Chung, R. Y., Whaley, J. M., Yandell, D. W., Farmer, G. E., Freiman, R. N., Lee, J. K., & Li, F. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5435 · Cited by 396 · see citing works

Oncogene Activation in Chemical Carcinogenesis

Balmain, A., & Brown, K. (1988) · Advances in cancer research · doi:10.1016/s0065-230x(08)60222-5 · Cited by 384 · see citing works

Frequent mutation of the p53 gene in human esophageal cancer.

Hollstein, M. C., Metcalf, R. A., Welsh, J. A., Montesano, R., & Harris, C. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9958 · Cited by 383 · see citing works

Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: The role of dna base damage

Breimer, L. H. (1990) · Molecular Carcinogenesis · doi:10.1002/mc.2940030405 · Cited by 367 · see citing works

p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.

Lehman, T. A., Bennett, W. P., Metcalf, R. A., Welsh, J. A., Ecker, J., Modali, R. V., Ullrich, S. J., Romano, J. W., Appella, E., & Testa, J. R. (1991) · PubMed · Cited by 349 · see citing works

Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.

You, M., Candrian, U., Maronpot, R. R., Stoner, G. D., & Anderson, M. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3070 · Cited by 336 · see citing works

A deadly inheritance

Vogelstein, B. (1990) · Nature · doi:10.1038/348681a0 · Cited by 332 · see citing works

Specific interaction between the p53 cellular tumour antigen and major heat shock proteins

Pinhasi-Kimhi, O., Michalovitz, D., Ben‐Ze'ev, A., & Oren, M. (1986) · Nature · doi:10.1038/320182a0 · Cited by 330 · see citing works

Frequent Mutations in the p53 Tumor Suppressor Gene in Human Leukemia T-Cell Lines

Cheng, J. F., & Haas, M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5502-5509.1990 · Cited by 316 · see citing works

Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.

Ahuja, H., Bar‐Eli, M., Advani, S. H., Benchimol, S., & Cline, M. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6783 · Cited by 284 · see citing works

Heterogeneous DNA damage and repair in the mammalian genome.

Bohr, V. A., Phillips, D. H., & Hanawalt, P. C. (1987) · PubMed · Cited by 276 · see citing works

Base substitution mutations induced by metabolically activated aflatoxin B1.

Foster, P. L., Eisenstadt, E., & Miller, J. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2695 · Cited by 275 · see citing works

Mechanisms of p53 loss in human sarcomas.

Mulligan, L. M., Matlashewski, G., Scrable, H. J., & Cavenee, W. K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5863 · Cited by 268 · see citing works

Mismatch-specific thymine DNA glycosylase and DNA polymerase beta mediate the correction of G.T mispairs in nuclear extracts from human cells.

Wiebauer, K., & Jiricny, J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5842 · Cited by 254 · see citing works

Meth A fibrosarcoma cells express two transforming mutant p53 species.

Eliyahu, D., Goldfinger, N., Pinhasi-Kimhi, O., Shaulsky, G., Skurnik, Y. D., Arai, N., Rotter, V., & Oren, M. (1988) · PubMed · Cited by 233 · see citing works

Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines.

Hinds, P. W., Finlay, C. A., Frey, A. B., & Levine, A. J. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2863 · Cited by 232 · see citing works

MUTATIONAL SPECIFICITY IN BACTERIA

Miller, J. H. (1983) · Annual Review of Genetics · doi:10.1146/annurev.ge.17.120183.001243 · Cited by 209 · see citing works

Aneuploidy: Etiology and mechanisms

(1987) · Gene · doi:10.1016/0378-1119(87)90063-1 · Cited by 201 · see citing works

Frequency and structure of p53 rearrangements in human osteosarcoma.

Miller, C. W., Aslo, A., Tsay, C., Slamon, D. J., Ishizaki, K., Toguchida, J., Yamamuro, T., Lampkin, B. C., & Koeffler, H. P. (1990) · PubMed · Cited by 196 · see citing works

Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair

Harris, C. C. (1989) · Carcinogenesis · doi:10.1093/carcin/10.9.1563 · Cited by 195 · see citing works

Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.

Wp, B., Hollstein, M., He, A., et al. (1991) · PubMed · Cited by 184 · see citing works

Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.

Prosser, J., Thompson, A. M., Cranston, G., & Evans, H. J. (1990) · PubMed · Cited by 167 · see citing works

Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells.

Hw, S., Chumakov, P. M., Wj, W., et al. (1987) · PubMed · Cited by 163 · see citing works

Mutational specificity of alkylating agents and the influence of DNA repair

Horsfall, M. J., Gordon, A. J. E., Burns, P. A., Zieleńska, M., van der Vliet, G. M. E., & Glickman, B. W. (1990) · Environmental and Molecular Mutagenesis · doi:10.1002/em.2850150208 · Cited by 158 · see citing works

Endogenous genotoxic agents and processes as a basis of spontaneous carcinogenesis

Lutz, W. K. (1990) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(90)90020-c · Cited by 139 · see citing works

Spontaneous deamination of cytosine and 5-methylcytosine residues in DNA and replacement of 5-methylcytosine residues with cytosine residues

Ehrlich, M., Zhang, X., & Inamdar, N. M. (1990) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(90)90019-8 · Cited by 127 · see citing works

Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors.

McMahon, G., Davis, E. F., Huber, L. J., et al. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1104 · Cited by 126 · see citing works

Effect of excision repair by diploid human fibroblasts on the kinds and locations of mutations induced by (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene in the coding region of the HPRT gene.

Chen, R., Maher, V. M., & McCormick, J. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8680 · Cited by 125 · see citing works

Sequence specificity in aflatoxin B1--DNA interactions.

Muench, K. F., Misra, R. P., & Humayun, M. Z. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.6 · Cited by 123 · see citing works

Sequence specificity of mutations induced by benzo[a]pyrene-7,8-diol-9,10-epoxide at endogenousaprt gene in CHO cells

Mazur, M., & Glickman, B. W. (1988) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534647 · Cited by 122 · see citing works

Aflatoxin—albumin adducts in human sera from different regions of the world

Wild, C. P., Jiang, Y.-T., Allen, S. J., et al. (1990) · Carcinogenesis · doi:10.1093/carcin/11.12.2271 · Cited by 120 · see citing works

Human pulmonary alveolar macrophages metabolise benzo(a)pyrene to proximate and ultimate mutagens

Harris, C. C., Hsu, I. C., Stoner, G. D., et al. (1978) · Nature · doi:10.1038/272633a0 · Cited by 100 · see citing works

Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.

Romano, J., Ehrhart, J., Duthu, A., et al. (1989) · PubMed · Cited by 96 · see citing works

Spectrum of spontaneous mutation at the APRT locus of Chinese hamster ovary cells: an analysis at the DNA sequence level.

de Jong, P. J., Grosovsky, A. J., & Glickman, B. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3499 · Cited by 93 · see citing works

Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen

Jenkins, J. R., Chumakov, P. M., Addison, C. M., et al. (1988) · Journal of Virology · doi:10.1128/jvi.62.10.3903-3906.1988 · Cited by 91 · see citing works

Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines.

Hosono, S., Cs, L., Mj, C., et al. (1991) · PubMed · Cited by 72 · see citing works

Errors in DNA synthesis: A source of spontaneous mutations

Loeb, L. A., & Cheng, K. C. (1990) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(90)90021-3 · Cited by 68 · see citing works

Markers of exposure to carcinogens.

Wogan, G. N. (1989) · Environmental Health Perspectives · doi:10.1289/ehp.89819 · Cited by 51 · see citing works

Preferential DNA Repair in Expressed Genes

Hanawalt, P. C. (1987) · Environmental Health Perspectives · doi:10.1289/ehp.87769 · Cited by 48 · see citing works

Mutational Spectrometry in Animal Toxicity Testing

Thilly, W. G. (1990) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.002101 · Cited by 28 · see citing works

The effect of the pyrrolizidine alkaloid integerrimine on the chromosomes of mouse bone marrow cells

Gimmler-Luz, M. C., Erdtmann, B., & Balbueno, R. A. (1990) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(90)90028-z · Cited by 20 · see citing works

Aneuploidy

Dellarco, V. L., Voytek, P. E., Hollaender, A., et al. (1985) · Springer eBooks · doi:10.1007/978-1-4613-2127-9 · Cited by 20 · see citing works

Detecting Mutations in Human Genes

Marx, J. L. (1989) · Science · doi:10.1126/science.2783787 · Cited by 7 · see citing works

Free radicals and antioxidants in normal physiological functions and human disease

Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry &amp; Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269 · see citing works

WAF1, a potential mediator of p53 tumor suppression

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · see citing works

Free radicals, metals and antioxidants in oxidative stress-induced cancer

Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680 · see citing works

Cancer Cell Cycles

Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · see citing works

p53, guardian of the genome

Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138 · see citing works

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · see citing works

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · see citing works

Cellular processing of platinum anticancer drugs

Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801 · see citing works

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335 · see citing works

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · see citing works

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · see citing works

p53 is required for radiation-induced apoptosis in mouse thymocytes

Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864 · see citing works

A microRNA component of the p53 tumour suppressor network

He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692 · see citing works

Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain

Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · see citing works

Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations

Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · see citing works

TP53 mutations in human cancers: origins, consequences, and clinical use.

Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199 · see citing works

Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113 · see citing works

Definition of a consensus binding site for p53

El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985 · see citing works

A role for sunlight in skin-cancer – UV-induced p53 mutations in squamous-cell carcinoma

Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., & Pontén, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10124 · Cited by 1,959 · see citing works

Amplification of a gene encoding a p53-associated protein in human sarcomas

Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949 · see citing works

8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.

Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844 · see citing works

The p53-mdm-2 autoregulatory feedback loop.

Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes &amp; Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801 · see citing works

Radical causes of cancer

Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · see citing works

Self-propagation of pathogenic protein aggregates in neurodegenerative diseases

Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663 · see citing works

Preferential Formation of Benzo[ <i>a</i> ]pyrene Adducts at Lung Cancer Mutational Hotspots in <i>P53</i>

Denissenko, M. F., Pao, A., Tang, M.-S., & Pfeifer, G. P. (1996) · Science · doi:10.1126/science.274.5286.430 · Cited by 1,650 · see citing works

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · see citing works

How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression

Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death &amp; Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395 · see citing works

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome

Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308 · see citing works

mdm2 expression is induced by wild type p53 activity.

Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290 · see citing works

Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280 · see citing works

Toxic effects of ultraviolet radiation on the skin

Matsumura, Y., & Ananthaswamy, H. N. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.08.019 · Cited by 1,270 · see citing works

The miR-34 family in cancer and apoptosis

Hermeking, H. (2010) · Cell Death &amp; Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236 · see citing works

A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

Mayo, L. D., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181181198 · Cited by 1,230 · see citing works

The multiple mechanisms that regulate p53 activity and cell fate

Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129 · see citing works

When mutants gain new powers: News from the mutant p53 field

Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132 · see citing works

Oxidative Stress in Aging Human Skin

Rinnerthaler, M., Bischof, J., Streubel, M., Trost, A., & Richter, K. (2015) · Biomolecules · doi:10.3390/biom5020545 · Cited by 1,053 · see citing works

p73 is a human p53-related protein that can induce apoptosis

Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948 · see citing works

Targeting mutant p53 for efficient cancer therapy

Bykov, V. J. N., Eriksson, S. E., Bianchi, J., & Wiman, K. G. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.109 · Cited by 889 · see citing works

Gain of function mutations in p53

Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., & Levine, A. J. (1993) · Nature Genetics · doi:10.1038/ng0593-42 · Cited by 894 · see citing works

TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes

Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884 · see citing works

Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia

Wong, T. N., Ramsingh, G., Young, A. L., Miller, C. A., Touma, W., Welch, J. S., Lamprecht, T. L., Shen, D., Hundal, J., Fulton, R. S., et al. (2015) · Nature · doi:10.1038/nature13968 · Cited by 892 · see citing works

p53-Dependent apoptosis suppresses tumor growth and progression in vivo

Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., & Van Dyke, T. (1994) · Cell · doi:10.1016/0092-8674(94)90534-7 · Cited by 880 · see citing works

p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8493 · Cited by 858 · see citing works

p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.

Chen, X., Ko, L. J., Jayaraman, L., & Prives, C. (1996) · Genes &amp; Development · doi:10.1101/gad.10.19.2438 · Cited by 735 · see citing works

A Compendium of Mutational Signatures of Environmental Agents

Kucab, J. E., Zou, X., Morganella, S., Joel, M., Nanda, A. S., Nagy, E., Gomez, C., Degasperi, A., Harris, R., Jackson, S. P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.001 · Cited by 660 · see citing works

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

Tovar, C., Rosinski, J., Filipovic, Z., Higgins, B., Kolinsky, K., Hilton, H., Zhao, X., Vu, B. T., Qing, W., Packman, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507493103 · Cited by 708 · see citing works

MDMX: a novel p53‐binding protein with some functional properties of MDM2.

Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648 · see citing works

GADD45 induction of a G ₂ /M cell cycle checkpoint

Wang, X. W., Zhan, Q., Coursen, J. D., Khan, M. A., Kontny, H. U., Yu, L., Hollander, M. C., O’Connor, P. M., Fornace, A. J., & Harris, C. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3706 · Cited by 634 · see citing works

Wild-type p53 activates transcription in vitro

Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579 · see citing works

PRIMA-1 reactivates mutant p53 by covalent binding to the core domain

Lambert, J. M. R., Gorzov, P., Veprintsev, D. B., Söderqvist, M., Segerbäck, D., Bergman, J., Fersht, A. R., Hainaut, P., Wiman, K. G., & Bykov, V. J. N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.003 · Cited by 592 · see citing works

Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

Chehab, N. H., Malikzay, A., Stavridi, E. S., & Halazonetis, T. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13777 · Cited by 583 · see citing works

p53: traffic cop at the crossroads of DNA repair and recombination

Sengupta, S., & Harris, C. C. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1546 · Cited by 544 · see citing works

Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.

Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542 · see citing works

MDM2 inhibitors for cancer therapy

Vassilev, L. T. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.11.002 · Cited by 532 · see citing works

Cancer and ageing: rival demons?

Campisi, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1073 · Cited by 512 · see citing works

Zinc deficiency, DNA damage and cancer risk

Ho, E. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2004.07.005 · Cited by 518 · see citing works

Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others

Sabapathy, K., & Lane, D. P. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.151 · Cited by 517 · see citing works

Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1

Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491 · see citing works

Mutational signatures: the patterns of somatic mutations hidden in cancer genomes

Alexandrov, L. B., & Stratton, M. R. (2014) · Current Opinion in Genetics &amp; Development · doi:10.1016/j.gde.2013.11.014 · Cited by 488 · see citing works

Regulating tumor suppressor genes: post-translational modifications

Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449 · see citing works

Escape from Therapy-Induced Accelerated Cellular Senescence in p53-Null Lung Cancer Cells and in Human Lung Cancers

Roberson, R. S., Kussick, S. J., Vallieres, E., Chen, S.-Y. J., & Wu, D. Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1270 · Cited by 428 · see citing works

Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line

Ortiz-Montero, P., Londoño-Vallejo, A., & Vernot, J.-P. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0172-3 · Cited by 428 · see citing works

Senescence-associated inflammatory responses: aging and cancer perspectives

Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408 · see citing works

NUMB controls p53 tumour suppressor activity

Colaluca, I. N., Tosoni, D., Nuciforo, P., Senic-Matuglia, F., Galimberti, V., Viale, G., Pece, S., & Di Fiore, P. P. (2008) · Nature · doi:10.1038/nature06412 · Cited by 385 · see citing works

Targeting a neoantigen derived from a common <i>TP53</i> mutation

Hsiue, E. H.-C., Wright, K. M., Douglass, J., Hwang, M. S., Mog, B. J., Pearlman, A. H., Paul, S., DiNapoli, S. R., Konig, M. F., Wang, Q., et al. (2021) · Science · doi:10.1126/science.abc8697 · Cited by 367 · see citing works

Opposing Effects of Ras on p53

Ries, S., Biederer, C., Woods, D., Shifman, O., Shirasawa, S., Sasazuki, T., McMahon, M., Oren, M., & McCormick, F. (2000) · Cell · doi:10.1016/s0092-8674(00)00123-9 · Cited by 357 · see citing works

PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy

Mayo, L. D., Dixon, J. E., Durden, D. L., Tonks, N. K., & Donner, D. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108302200 · Cited by 351 · see citing works

Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol

Cooney, R. V., Franke, A. A., Harwood, P. J., Hatch-Pigott, V, Custer, L. J., & Mordan, L. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1771 · Cited by 343 · see citing works

Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53

Mack, D. H., Vartikar, J., Pipas, J. M., & Laimins, L. A. (1993) · Nature · doi:10.1038/363281a0 · Cited by 322 · see citing works

Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer

Shi, R., Radulovich, N., Ng, C., Liu, N., Notsuda, H., Cabanero, M., Martins-Filho, S. N., Raghavan, V., Li, Q., Mer, A. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1376 · Cited by 316 · see citing works

The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.

Finlay, C. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.301 · Cited by 311 · see citing works

Mutations With Loss of Heterozygosity of p53 Are Common in Therapy-Related Myelodysplasia and Acute Myeloid Leukemia After Exposure to Alkylating Agents and Significantly Associated With Deletion or Loss of 5q, a Complex Karyotype, and a Poor Prognosis

Christiansen, D. H., Andersen, M. K., & Pedersen-Bjergaard, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1405 · Cited by 308 · see citing works

Increased activity of p53 in senescing fibroblasts

Atadja, P., Wong, H., Garkavtsev, I., Veillette, C., & Riabowol, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8348 · Cited by 308 · see citing works

Regulation of the Human hsp70 Promoter by p53

Agoff, S. N., Hou, J., Linzer, D. I., & Wu, B. (1993) · Science · doi:10.1126/science.8418500 · Cited by 292 · see citing works

Deficiencies in Mouse <b> <i>Myh</i> </b> and <b> <i>Ogg1</i> </b> Result in Tumor Predisposition and G to T Mutations in Codon 12 of the <b> <i>K-Ras</i> </b> Oncogene in Lung Tumors

Xie, Y., Yang, H., Cunanan, C., Okamoto, K., Shibata, D., Pan, J., Barnes, D. E., Lindahl, T., McIlhatton, M., Fishel, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3834 · Cited by 291 · see citing works

Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide

Thomas, D. D., Espey, M. G., Ridnour, L. A., Hofseth, L. J., Mancardi, D., Harris, C. C., & Wink, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400453101 · Cited by 289 · see citing works

A High-Enrollment Course-Based Undergraduate Research Experience Improves Student Conceptions of Scientific Thinking and Ability to Interpret Data

Brownell, S. E., Hekmat-Scafe, D. S., Singla, V., Chandler Seawell, P., Conklin Imam, J. F., Eddy, S. L., Stearns, T., & Cyert, M. S. (2015) · CBE—Life Sciences Education · doi:10.1187/cbe.14-05-0092 · Cited by 287 · see citing works

Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression

Carroll, P. E., Okuda, M., Horn, H. F., Biddinger, P., Stambrook, P. J., Gleich, L. L., Li, Y.-Q., Tarapore, P., & Fukasawa, K. (1999) · Oncogene · doi:10.1038/sj.onc.1202515 · Cited by 279 · see citing works

p53 in recombination and repair

Gatz, S. A., & Wiesmüller, L. (2006) · Cell Death &amp; Differentiation · doi:10.1038/sj.cdd.4401903 · Cited by 242 · see citing works

Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression

Ambs, S., Hussain, S. P., & Harris, C. C. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194524 · Cited by 233 · see citing works

Functional Analysis of the Roles of Posttranslational Modifications at the p53 C Terminus in Regulating p53 Stability and Activity

Feng, L., Lin, T., Uranishi, H., Gu, W., & Xu, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5389-5395.2005 · Cited by 236 · see citing works

Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors

Wei, M., Wanibuchi, H., Morimura, K., Iwai, S., Yoshida, K., Endo, G., Nakae, D., & Fukushima, S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1387 · Cited by 222 · see citing works

Regional analysis of <i>p53</i> mutations in rheumatoid arthritis synovium

Yamanishi, Y., Boyle, D. L., Rosengren, S., Green, D. R., Zvaifler, N. J., & Firestein, G. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152333199 · Cited by 214 · see citing works

Molecular markers of early pancreatic cancer

Goggins, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.19.711 · Cited by 214 · see citing works

An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors

Latronico, A. C., Pinto, E. M., Domenice, S., Fragoso, M. C. B. V., Martin, R. M., Zerbini, M. C., Lucon, A. M., & Mendonca, B. B. (2001) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jcem.86.10.7957 · Cited by 224 · see citing works

Overexpression of VEGF and Angiopoietin 2: A Key to High Vascularity of Hepatocellular Carcinoma?

Moon, W. S., Rhyu, K. H., Kang, M. J., Lee, D. G., Yu, H. C., Yeum, J. H., Koh, G. Y., & Tarnawski, A. S. (2003) · Modern Pathology · doi:10.1097/01.mp.0000071841.17900.69 · Cited by 210 · see citing works

The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis

Liu, G., & Chen, X. (2002) · Oncogene · doi:10.1038/sj.onc.1205862 · Cited by 207 · see citing works

Intact p53-Dependent Responses in miR-34–Deficient Mice

Concepcion, C. P., Han, Y.-C., Mu, P., Bonetti, C., Yao, E., D'Andrea, A., Vidigal, J. A., Maughan, W. P., Ogrodowski, P., & Ventura, A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002797 · Cited by 197 · see citing works

The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability

Overholtzer, M., Rao, P. H., Favis, R., Lu, X.-Y., Elowitz, M. B., Barany, F., Ladanyi, M., Gorlick, R., & Levine, A. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934852100 · Cited by 193 · see citing works

Mechanisms of DNA Oxidation

Aust, A. E., & Eveleigh, J. F. (1999) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-141.x · Cited by 191 · see citing works

PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting

Dziadkowiec, K. N., Gąsiorowska, E., Nowak-Markwitz, E., & Jankowska, A. (2016) · Menopausal Review · doi:10.5114/pm.2016.65667 · Cited by 191 · see citing works

Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA

Léveillé, N., Melo, C. A., Rooijers, K., Díaz-Lagares, A., Melo, S. A., Korkmaz, G., Lopes, R., Moqadam, F. A., Maia, A. R., Wijchers, P. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7520 · Cited by 183 · see citing works

Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer

Speetjens, F. M., Kuppen, P. J. K., Welters, M. J. P., Essahsah, F., Voet van den Brink, A. M. E. G., Lantrua, M. G. K., Valentijn, A. R. P. M., Oostendorp, J., Fathers, L. M., Nijman, H. W., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2227 · Cited by 185 · see citing works

p53 and regulation of DNA damage recognition during nucleotide excision repair

Adimoolam, S., & Ford, J. M. (2003) · DNA Repair · doi:10.1016/s1568-7864(03)00087-9 · Cited by 181 · see citing works

Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint

Kleiblova, P., Shaltiel, I. A., Benada, J., &#x8a;evčík, J., Pecháčková, S., Pohlreich, P., Voest, E. E., Dundr, P., Bartek, J., Kleibl, Z., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201210031 · Cited by 170 · see citing works

The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors

Koch, C. A., Pacak, K., & Chrousos, G. P. (2002) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2002-021069 · Cited by 177 · see citing works

Requirement for p27^KIP1 in Retinoblastoma Protein-Mediated Senescence

Alexander, K., & Hinds, P. W. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.11.3616-3631.2001 · Cited by 164 · see citing works

The role of ubiquitin modification in the regulation of p53

Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168 · see citing works

Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer

Ambs, S., Bennett, W. P., Merriam, W. G., Ogunfusika, M. O., Oser, S. M., Harrington, A. M., Shields, P. G., Felley-Bosco, E., Hussain, S. P., & Harris, C. C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.86 · Cited by 166 · see citing works

Levels of Analysis in Health Science: A Framework for Integrating Sociobehavioral and Biomedical Research

ANDERSON, N. B. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09595.x · Cited by 165 · see citing works

[Granular cell tumors of the esophagus. Apropos of a case combined with an epidermoid carcinoma of the esophagus].

Letessier, E., Aillet, G., Lehur, P. A., et al. (1988) · PubMed · Cited by 3 · see citing works

X-ray analysis of esophagus small cell carcinoma

Ming-ya, W. (2004) · Journal of Rare and Uncommon Disease

[Comparative analysis chest CT 3D reconstruction and esophagus barium swallow in esophagus foreign body].

Xu, K. L., Chu, H., Huang, X.-W., et al. (2010) · PubMed · Cited by 7 · see citing works

Tumors of the Esophagus: Cancers of The esophagus, Surgical Treatment of Cancer of the Esophagus, Benign Tumors of the Esophagus, Surgical Treatment of

(1956) · Gastroenterology · doi:10.1016/s0016-5085(56)80055-3

Experimental study of esophagus reconstruction with biological artificial esophagus in dogs

Ma, Z. F. (2003) · Zhonghua xiaohua zazhi · Cited by 1 · see citing works